Hansoh Pharma (03692): Yan Jia appointed as independent non-executive director

HANSOH PHARMA (03692) announced that Mr. Yan Jia has been appointed as an independent non-executive director, and also as a member of the Company's Audit Committee and the Environmental, Social and Governance Committee, effective from December 26, 2025. Due to personal work arrangements, Ms. Huang Huanqi has resigned from the position of Joint Company Secretary of the Company, and will no longer serve as the authorized representative under Rule 3.05 of the Listing Rules, as well as the authorized representative (legal process agent) for receiving legal process documents and notices of the Company in Hong Kong under Rule 19.05(2) of the Listing Rules and Part 16 of the Company Ordinance (Chapter 622 of the Laws of Hong Kong), effective from December 26, 2025. Mr. Li Liangxian has been appointed as the Joint Company Secretary, and he has also been appointed as the authorized representative and legal process agent, effective from December 26, 2025.